Amphastar Pharmaceuticals' (NASDAQ:AMPH) stock is up by 3.0% over the past week. Given that the market rewards strong...
Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies have been highlighted in this Industry Outlook article.
The impact of inflationary headwinds and pricing pressure on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and SLGL.